Insmed Incorporated (INSM)
USD 68.4
(-6.72%)
USD 68.4
(-6.72%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.66 Billion USD | 5.95% |
| 2022 | 1.56 Billion USD | 88.28% |
| 2021 | 833.04 Million USD | 60.12% |
| 2020 | 520.27 Million USD | 8.25% |
| 2019 | 480.62 Million USD | 21.28% |
| 2018 | 396.29 Million USD | 292.41% |
| 2017 | 100.98 Million USD | 20.98% |
| 2016 | 83.47 Million USD | 86.08% |
| 2015 | 44.85 Million USD | 0.52% |
| 2014 | 44.62 Million USD | 34.52% |
| 2013 | 33.17 Million USD | 1.51% |
| 2012 | 32.67 Million USD | 487.12% |
| 2011 | 5.56 Million USD | 62.65% |
| 2010 | 3.42 Million USD | 23.05% |
| 2009 | 2.78 Million USD | -63.32% |
| 2008 | 7.58 Million USD | -5.38% |
| 2007 | 8.01 Million USD | -44.62% |
| 2006 | 14.46 Million USD | 17.24% |
| 2005 | 12.34 Million USD | 113.66% |
| 2004 | 5.77 Million USD | 60.8% |
| 2003 | 3.59 Million USD | -26.09% |
| 2002 | 4.86 Million USD | -59.2% |
| 2001 | 11.91 Million USD | 100.66% |
| 2000 | 5.93 Million USD | 611.8% |
| 1999 | 833.94 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 1.56 Billion USD | -11.39% |
| 2024 Q2 | 1.77 Billion USD | 9.08% |
| 2024 Q1 | 1.62 Billion USD | -2.28% |
| 2023 Q1 | 1.56 Billion USD | -0.39% |
| 2023 FY | 1.66 Billion USD | 5.95% |
| 2023 Q3 | 1.61 Billion USD | 1.21% |
| 2023 Q4 | 1.66 Billion USD | 2.94% |
| 2023 Q2 | 1.59 Billion USD | 2.08% |
| 2022 Q4 | 1.56 Billion USD | 53.06% |
| 2022 Q2 | 1 Billion USD | -2.35% |
| 2022 Q1 | 1.03 Billion USD | 24.06% |
| 2022 FY | 1.56 Billion USD | 88.28% |
| 2022 Q3 | 1.02 Billion USD | 1.55% |
| 2021 Q3 | 806.92 Million USD | 15.49% |
| 2021 FY | 833.04 Million USD | 60.12% |
| 2021 Q1 | 490.75 Million USD | -5.67% |
| 2021 Q2 | 698.73 Million USD | 42.38% |
| 2021 Q4 | 833.04 Million USD | 3.24% |
| 2020 FY | 520.27 Million USD | 8.25% |
| 2020 Q1 | 469.82 Million USD | -2.25% |
| 2020 Q2 | 480.04 Million USD | 2.18% |
| 2020 Q3 | 483.65 Million USD | 0.75% |
| 2020 Q4 | 520.27 Million USD | 7.57% |
| 2019 Q2 | 446.21 Million USD | -1.23% |
| 2019 Q3 | 459.07 Million USD | 2.88% |
| 2019 Q4 | 480.62 Million USD | 4.69% |
| 2019 Q1 | 451.77 Million USD | 14.0% |
| 2019 FY | 480.62 Million USD | 21.28% |
| 2018 FY | 396.29 Million USD | 292.41% |
| 2018 Q4 | 396.29 Million USD | 7.07% |
| 2018 Q3 | 370.1 Million USD | 4.67% |
| 2018 Q2 | 353.6 Million USD | 4.52% |
| 2018 Q1 | 338.29 Million USD | 234.99% |
| 2017 Q4 | 100.98 Million USD | 18.95% |
| 2017 Q3 | 84.9 Million USD | 3.29% |
| 2017 Q2 | 82.19 Million USD | 4.08% |
| 2017 Q1 | 78.97 Million USD | -5.39% |
| 2017 FY | 100.98 Million USD | 20.98% |
| 2016 Q3 | 58.81 Million USD | 19.75% |
| 2016 FY | 83.47 Million USD | 86.08% |
| 2016 Q4 | 83.47 Million USD | 41.92% |
| 2016 Q2 | 49.11 Million USD | 8.56% |
| 2016 Q1 | 45.24 Million USD | 0.86% |
| 2015 Q3 | 46.74 Million USD | 8.28% |
| 2015 Q1 | 41.28 Million USD | -7.48% |
| 2015 FY | 44.85 Million USD | 0.52% |
| 2015 Q2 | 43.16 Million USD | 4.56% |
| 2015 Q4 | 44.85 Million USD | -4.03% |
| 2014 Q2 | 38.56 Million USD | 10.55% |
| 2014 Q3 | 36.17 Million USD | -6.19% |
| 2014 Q4 | 44.62 Million USD | 23.36% |
| 2014 FY | 44.62 Million USD | 34.52% |
| 2014 Q1 | 34.88 Million USD | 5.15% |
| 2013 Q1 | 35.41 Million USD | 8.36% |
| 2013 Q4 | 33.17 Million USD | 1.06% |
| 2013 FY | 33.17 Million USD | 1.51% |
| 2013 Q3 | 32.82 Million USD | -2.13% |
| 2013 Q2 | 33.54 Million USD | -5.28% |
| 2012 Q4 | 32.67 Million USD | 106.24% |
| 2012 Q2 | 16.33 Million USD | 219.12% |
| 2012 Q1 | 5.11 Million USD | -8.03% |
| 2012 FY | 32.67 Million USD | 487.12% |
| 2012 Q3 | 15.84 Million USD | -3.01% |
| 2011 Q1 | 4.66 Million USD | 36.35% |
| 2011 FY | 5.56 Million USD | 62.65% |
| 2011 Q4 | 5.56 Million USD | 49.34% |
| 2011 Q3 | 3.72 Million USD | 4.99% |
| 2011 Q2 | 3.55 Million USD | -23.92% |
| 2010 Q1 | 2.46 Million USD | -11.43% |
| 2010 Q2 | 3.01 Million USD | 22.53% |
| 2010 Q4 | 3.42 Million USD | 48.78% |
| 2010 Q3 | 2.3 Million USD | -23.79% |
| 2010 FY | 3.42 Million USD | 23.05% |
| 2009 Q1 | 13.38 Million USD | 76.55% |
| 2009 Q2 | 4.61 Million USD | -65.51% |
| 2009 Q3 | 3.58 Million USD | -22.36% |
| 2009 Q4 | 2.78 Million USD | -22.41% |
| 2009 FY | 2.78 Million USD | -63.32% |
| 2008 FY | 7.58 Million USD | -5.38% |
| 2008 Q2 | 9.26 Million USD | 18.4% |
| 2008 Q3 | 7.41 Million USD | -19.94% |
| 2008 Q4 | 7.58 Million USD | 2.25% |
| 2008 Q1 | 7.82 Million USD | -2.37% |
| 2007 Q1 | 12.01 Million USD | -16.94% |
| 2007 Q2 | 7.64 Million USD | -36.38% |
| 2007 Q4 | 8.01 Million USD | -1.79% |
| 2007 FY | 8.01 Million USD | -44.62% |
| 2007 Q3 | 8.15 Million USD | 6.71% |
| 2006 Q1 | 8.06 Million USD | -34.68% |
| 2006 Q4 | 14.46 Million USD | 27.72% |
| 2006 Q3 | 11.32 Million USD | 3.42% |
| 2006 Q2 | 10.95 Million USD | 35.88% |
| 2006 FY | 14.46 Million USD | 17.24% |
| 2005 Q4 | 12.34 Million USD | -36.56% |
| 2005 FY | 12.34 Million USD | 113.66% |
| 2005 Q3 | 19.45 Million USD | -20.98% |
| 2005 Q1 | 23.57 Million USD | 308.17% |
| 2005 Q2 | 24.61 Million USD | 4.42% |
| 2004 FY | 5.77 Million USD | 60.8% |
| 2004 Q1 | 3.87 Million USD | 7.93% |
| 2004 Q2 | 6.39 Million USD | 64.92% |
| 2004 Q3 | 6.7 Million USD | 4.79% |
| 2004 Q4 | 5.77 Million USD | -13.79% |
| 2003 Q2 | 4.48 Million USD | 8.88% |
| 2003 Q3 | 3.95 Million USD | -11.75% |
| 2003 Q4 | 3.59 Million USD | -9.27% |
| 2003 FY | 3.59 Million USD | -26.09% |
| 2003 Q1 | 4.12 Million USD | -15.23% |
| 2002 Q2 | 8.67 Million USD | -3.99% |
| 2002 Q3 | 7.41 Million USD | -14.47% |
| 2002 FY | 4.86 Million USD | -59.2% |
| 2002 Q1 | 9.03 Million USD | -24.17% |
| 2002 Q4 | 4.86 Million USD | -34.47% |
| 2001 Q1 | 6.68 Million USD | 12.69% |
| 2001 Q3 | 8.24 Million USD | -2.53% |
| 2001 Q4 | 11.91 Million USD | 44.41% |
| 2001 FY | 11.91 Million USD | 100.66% |
| 2001 Q2 | 8.46 Million USD | 26.51% |
| 2000 Q3 | 7.29 Million USD | 97.54% |
| 2000 Q1 | 1.34 Million USD | 0.0% |
| 2000 FY | 5.93 Million USD | 611.8% |
| 2000 Q2 | 3.69 Million USD | 174.37% |
| 2000 Q4 | 5.93 Million USD | -18.63% |
| 1999 FY | 833.94 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -394.901% |
| Alkermes plc | 933.53 Million USD | -78.007% |
| Agenus Inc. | 462.29 Million USD | -259.459% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 58.974% |
| Aptorum Group Limited | 5.25 Million USD | -31512.0% |
| Ardelyx, Inc. | 130.76 Million USD | -1170.818% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -247.365% |
| Bicycle Therapeutics plc | 224.41 Million USD | -640.495% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1176.215% |
| ChromaDex Corporation | 26.5 Million USD | -6168.9% |
| Chimerix, Inc. | 19.74 Million USD | -8316.105% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -4623.98% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -2189.967% |
| CRISPR Therapeutics AG | 346.76 Million USD | -379.214% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1079.222% |
| Dyadic International, Inc. | 2.34 Million USD | -70895.633% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -10118.041% |
| Fortress Biotech, Inc. | 165.93 Million USD | -901.428% |
| Lantern Pharma Inc. | 2.73 Million USD | -60555.215% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -2224.79% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -46992.363% |
| Incyte Corporation | 1.59 Billion USD | -4.364% |
| IO Biotech, Inc. | 17.55 Million USD | -9365.482% |
| Jaguar Health, Inc. | 45.86 Million USD | -3523.076% |
| Novavax, Inc. | 2.57 Billion USD | 35.397% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -4508.575% |
| Opthea Limited | 264.6 Million USD | -528.024% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1171.363% |
| ContextLogic Inc. | 206 Million USD | -706.68% |
| MiMedx Group, Inc. | 96.33 Million USD | -1625.07% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -3360.414% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -46990.202% |
| NextCure, Inc. | 14.99 Million USD | -10980.616% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -41012.321% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -24787.824% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -3455.403% |
| Vaxcyte, Inc. | 167.44 Million USD | -892.398% |
| PDS Biotechnology Corporation | 33.25 Million USD | -4896.402% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -606.489% |
| Pharming Group N.V. | 244.07 Million USD | -580.845% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -13838.601% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1200.373% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -25050.444% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -25050.444% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1915.892% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -24915.204% |
| Acelyrin, Inc. | 86.35 Million USD | -1824.38% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -127802.368% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -11456.854% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1226.68% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -17430.963% |
| Senti Biosciences, Inc. | 52.57 Million USD | -3060.982% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -2316.157% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -996.784% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -84857.055% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -124323.839% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -632.595% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -17640.579% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -630.621% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -236.042% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -15125.948% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -5940.347% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -13628.222% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -241.504% |
| Immix Biopharma, Inc. | 3.72 Million USD | -44549.567% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -4294.795% |
| MEI Pharma, Inc. | 8.35 Million USD | -19789.408% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -5627.245% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -378.094% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1039.214% |
| Fortress Biotech, Inc. | 165.93 Million USD | -901.428% |
| Precigen, Inc. | 41.64 Million USD | -3890.395% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -3228.179% |
| AlloVir, Inc. | 45.01 Million USD | -3591.569% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1174.972% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1105.922% |
| ImmuCell Corporation | 18.81 Million USD | -8732.09% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -5787.338% |
| Onconetix, Inc. | 23.18 Million USD | -7068.664% |
| PureTech Health plc | 125.58 Million USD | -1223.236% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -18467.151% |
| Elevation Oncology, Inc. | 34.28 Million USD | -4747.325% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -67865.644% |
| Seer, Inc. | 39.36 Million USD | -4121.415% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -2587.454% |
| Innoviva, Inc. | 568.55 Million USD | -192.279% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -6003.129% |
| ESSA Pharma Inc. | 3.49 Million USD | -47445.815% |
| GlycoMimetics, Inc. | 6.9 Million USD | -23976.241% |
| GT Biopharma, Inc. | 6.63 Million USD | -24952.917% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -528.526% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -510.297% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1877.674% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -16901.842% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -6016.383% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -51415.094% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2152.715% |
| Aptose Biosciences Inc. | 15.8 Million USD | -10411.68% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -14952.602% |
| Soligenix, Inc. | 7.27 Million USD | -22742.363% |
| Century Therapeutics, Inc. | 175.94 Million USD | -844.498% |
| Kura Oncology, Inc. | 51.66 Million USD | -3116.6% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1270.162% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -40107.113% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -25025.437% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -557.867% |
| Autolus Therapeutics plc | 263.9 Million USD | -529.676% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -15753.463% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1770.067% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -3443.274% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -370.946% |
| GRI Bio, Inc. | 2.69 Million USD | -61515.128% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -205160.72% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -5244.826% |
| IGM Biosciences, Inc. | 220.17 Million USD | -654.738% |
| INmune Bio, Inc. | 18.86 Million USD | -8710.094% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -547.913% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -6137.414% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -61029.942% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -50559.306% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -2742.802% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1628.138% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -527.707% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -101.908% |
| Verastem, Inc. | 71.18 Million USD | -2234.424% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -3279.209% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -4207.533% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -3296.06% |
| Histogen Inc. | 5.69 Million USD | -29069.036% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -37791.237% |
| Surrozen, Inc. | 8.14 Million USD | -20302.21% |
| Organovo Holdings, Inc. | 2.74 Million USD | -60371.616% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -529362.368% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2855.296% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -9963.953% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -3151.786% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -200868.707% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1211.312% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -15267.329% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1001.313% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -63633.798% |
| Apollomics, Inc. | 14.15 Million USD | -11641.398% |
| Amarin Corporation plc | 279.58 Million USD | -494.362% |
| Mesoblast Limited | 188.79 Million USD | -780.179% |
| Turnstone Biologics Corp. | 14.14 Million USD | -11645.547% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -819.176% |
| Synaptogenix, Inc. | 5.52 Million USD | -29952.795% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -24896.39% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -876.885% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -19319.452% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -94458.246% |
| Exelixis, Inc. | 678.44 Million USD | -144.937% |
| Better Therapeutics, Inc. | 23.84 Million USD | -6869.885% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -912.984% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -179.659% |
| NLS Pharmaceutics AG | 10.68 Million USD | -15459.253% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -102249.324% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -4168.914% |
| Gritstone bio, Inc. | 125.91 Million USD | -1219.706% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -11222.976% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -32556.353% |
| Avid Bioservices, Inc. | 275.66 Million USD | -502.812% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -21498.061% |
| MediWound Ltd. | 27.18 Million USD | -6012.333% |
| OmniAb, Inc. | 87.4 Million USD | -1801.327% |
| Alector, Inc. | 487.66 Million USD | -240.756% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -311.881% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -8919.05% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -4230.545% |
| Zai Lab Limited | 240.17 Million USD | -591.89% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -163.747% |
| Aura Biosciences, Inc. | 29.22 Million USD | -5585.702% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1647.804% |
| Immunic, Inc. | 25.36 Million USD | -6450.615% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -2300.139% |
| Veracyte, Inc. | 93.71 Million USD | -1673.13% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -63406.598% |
| FibroGen, Inc. | 585.72 Million USD | -183.708% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -9459.685% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -254351.243% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -29283.297% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 78.296% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -20170.31% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1877.768% |
| TG Therapeutics, Inc. | 169.08 Million USD | -882.796% |
| Galecto, Inc. | 5.89 Million USD | -28084.532% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -19959.874% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 36.535% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -5665.596% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -13066.627% |
| XBiotech Inc. | 8.39 Million USD | -19689.925% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -11222.976% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -3024.784% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -357.651% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -6081.223% |
| Theravance Biopharma, Inc. | 169 Million USD | -883.267% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -36.703% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -232.069% |
| Vaxxinity, Inc. | 30.94 Million USD | -5270.217% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -70.877% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -27453.151% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -122.985% |
| NexImmune, Inc. | 5.08 Million USD | -32584.582% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -447338.569% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -53943.647% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 76.618% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -32141.954% |
| Scopus BioPharma Inc. | 7.45 Million USD | -22192.236% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -6219.921% |
| Ainos, Inc. | 7.39 Million USD | -22373.761% |
| Pluri Inc. | 34.11 Million USD | -4771.482% |
| Prothena Corporation plc | 135.01 Million USD | -1130.778% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -583.562% |
| Celularity Inc. | 102.92 Million USD | -1514.472% |
| Rallybio Corporation | 9.43 Million USD | -17510.852% |
| Cue Biopharma, Inc. | 24.44 Million USD | -6697.955% |
| MeiraGTx Holdings plc | 319.99 Million USD | -419.315% |
| Omeros Corporation | 403.25 Million USD | -312.09% |
| Humacyte, Inc. | 114.67 Million USD | -1349.079% |
| Immunocore Holdings plc | 228.15 Million USD | -628.337% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -33987.385% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -2065.442% |
| Blueprint Medicines Corporation | 918.64 Million USD | -80.893% |
| CalciMedica, Inc. | 4.02 Million USD | -41155.214% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -9421.889% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -978.064% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1836.4% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -498.201% |
| Pulmatrix, Inc. | 15.96 Million USD | -10310.073% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -10435.472% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -6653.475% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -562.563% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -3172.082% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -37.263% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -5128.455% |
| Nutriband Inc. | 1.07 Million USD | -153920.83% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -15528.327% |
| Vor Biopharma Inc. | 59.1 Million USD | -2711.586% |
| Roivant Sciences Ltd. | 773.95 Million USD | -114.711% |
| Evogene Ltd. | 17.99 Million USD | -9137.132% |
| ProKidney Corp. | 29.21 Million USD | -5587.842% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -2208.673% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -235616.322% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 12.026% |
| CorMedix Inc. | 11.91 Million USD | -13843.831% |
| BioLineRx Ltd. | 50.7 Million USD | -3177.504% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1011.85% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1778.948% |
| Atai Life Sciences N.V. | 49.16 Million USD | -3280.172% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -5234.308% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -9151.531% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1233.291% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -29290.874% |
| MediciNova, Inc. | 3.89 Million USD | -42601.718% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -8991.088% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -110371.66% |
| GeoVax Labs, Inc. | 3.51 Million USD | -47110.687% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -318.306% |
| Biomea Fusion, Inc. | 30.69 Million USD | -5314.663% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 38.945% |
| Mereo BioPharma Group plc | 15.96 Million USD | -10310.725% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -5225.983% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -2731.709% |
| Absci Corporation | 58.3 Million USD | -2750.165% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8624.066% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -5082.958% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2152.012% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1799.523% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -4820.817% |
| Allakos Inc. | 74.79 Million USD | -2121.812% |
| Imunon, Inc. | 8.53 Million USD | -19380.385% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -7285.272% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1347.375% |
| BioAtla, Inc. | 48.98 Million USD | -3292.316% |
| NLS Pharmaceutics AG | 10.68 Million USD | -15459.253% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -59697.049% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1172.365% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -11590.186% |
| XOMA Corporation | 145.58 Million USD | -1041.475% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -4836.165% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -2316.789% |
| aTyr Pharma, Inc. | 31.59 Million USD | -5159.233% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -2587.932% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -3595.674% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -3333.247% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -57801.045% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -20269.654% |
| Akari Therapeutics, Plc | 4.58 Million USD | -36151.309% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -9270.935% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -0.746% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -411320.422% |
| UroGen Pharma Ltd. | 243.52 Million USD | -582.383% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -417.542% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -60074.727% |
| Orgenesis Inc. | 35.53 Million USD | -4576.404% |
| Entera Bio Ltd. | 1.37 Million USD | -120404.714% |
| GH Research PLC | 6.7 Million USD | -24698.687% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -24337.647% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -8726.941% |
| Xencor, Inc. | 283.55 Million USD | -486.037% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -55557.766% |
| Replimune Group, Inc. | 113.21 Million USD | -1367.804% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -44129.564% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1505.1% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -411320.422% |
| Portage Biotech Inc. | 4.45 Million USD | -37242.921% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -110371.66% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -7109.371% |
| OncoCyte Corporation | 49.29 Million USD | -3270.847% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -40070.131% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -208275.34% |
| Purple Biotech Ltd. | 10 Million USD | -16509.295% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -28620.359% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2802.08% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -13314.249% |
| HilleVax, Inc. | 78.9 Million USD | -2005.919% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -32806.139% |
| Tharimmune, Inc. | 1.81 Million USD | -91454.704% |
| Genprex, Inc. | 3.25 Million USD | -50964.96% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -6027.66% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -31637.204% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -806579.612% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -463369.326% |
| OKYO Pharma Limited | 7.42 Million USD | -22293.134% |
| Savara Inc. | 37.19 Million USD | -4368.058% |
| Curis, Inc. | 57.61 Million USD | -2784.399% |
| Daré Bioscience, Inc. | 26.32 Million USD | -6211.315% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -4139.206% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -114980.332% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -7881.94% |
| BeiGene, Ltd. | 2.23 Billion USD | 25.607% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -7705.428% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -533.3% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -7711.225% |
| Erasca, Inc. | 78.61 Million USD | -2013.903% |
| bluebird bio, Inc. | 424.62 Million USD | -291.349% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -253506.246% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 12.079% |
| DBV Technologies S.A. | 42.8 Million USD | -3782.617% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -253506.246% |
| Moderna, Inc. | 4.57 Billion USD | 63.654% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -23656.397% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -100247.826% |
| Molecular Templates, Inc. | 31.17 Million USD | -5231.109% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -9634.974% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -182.563% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1234.693% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -5956.639% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -4458.262% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2886.897% |
| MacroGenics, Inc. | 154.2 Million USD | -977.616% |
| RenovoRx, Inc. | 4.46 Million USD | -37109.136% |
| Adicet Bio, Inc. | 37.12 Million USD | -4376.724% |
| Prime Medicine, Inc. | 60.78 Million USD | -2634.057% |
| Aditxt, Inc. | 28.53 Million USD | -5724.288% |
| Adagene Inc. | 45.16 Million USD | -3578.956% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -919518.596% |
| Quantum-Si incorporated | 26.63 Million USD | -6139.946% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -138.223% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -54519.355% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1345.499% |
| SciSparc Ltd. | 1.59 Million USD | -104085.58% |
| Vericel Corporation | 127.7 Million USD | -1201.249% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -29761.485% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1846.81% |
| Generation Bio Co. | 171.63 Million USD | -868.222% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -14287.532% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -3872.556% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -557.607% |
| Invivyd, Inc. | 51.71 Million USD | -3113.428% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1706.713% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -25444.902% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -2101.123% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -162658.08% |
| 2seventy bio, Inc. | 310.12 Million USD | -435.834% |
| ADMA Biologics, Inc. | 193.97 Million USD | -756.683% |
| Clene Inc. | 38.95 Million USD | -4166.283% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -4499.027% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -546.66% |
| GeoVax Labs, Inc. | 3.51 Million USD | -47110.687% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -773.402% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -13543.728% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -737.91% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -13526.792% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -3354.013% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -3044.831% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -349.302% |
| Evaxion Biotech A/S | 17.61 Million USD | -9332.45% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -932.604% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -984.799% |
| Trevena, Inc. | 48.26 Million USD | -3343.206% |
| Surrozen, Inc. | 8.14 Million USD | -20302.21% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -7595.115% |
| Cingulate Inc. | 10.36 Million USD | -15938.815% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -60327.636% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -4356.076% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -46233.493% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -12536.958% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -423.882% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -6587.432% |
| Clearmind Medicine Inc. | 3.61 Million USD | -45932.031% |
| Kronos Bio, Inc. | 54.2 Million USD | -2965.921% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -3432.428% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -7201.316% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -8179.408% |
| Statera Biopharma, Inc. | 22.67 Million USD | -7228.13% |
| ImmunityBio, Inc. | 1.09 Billion USD | -52.401% |
| Korro Bio, Inc. | 51.75 Million USD | -3111.006% |
| Kineta, Inc. | 7.22 Million USD | -22909.693% |
| BioVie Inc. | 9.7 Million USD | -17027.785% |
| Codexis, Inc. | 49.94 Million USD | -3227.113% |
| Celularity Inc. | 102.92 Million USD | -1514.472% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1626.558% |
| Celcuity Inc. | 51.45 Million USD | -3129.849% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -481298.866% |
| Cibus, Inc. | 206.11 Million USD | -706.222% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -3812.325% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -6209.123% |
| IN8bio, Inc. | 8.77 Million USD | -18843.912% |
| Kodiak Sciences Inc. | 213.59 Million USD | -678.01% |
| Annexon, Inc. | 47.11 Million USD | -3426.805% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1755.865% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1624.318% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -12039.382% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 36.169% |
| Eyenovia, Inc. | 19.78 Million USD | -8301.094% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -838.392% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -21534.683% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -6795.556% |
| Arcellx, Inc. | 339.75 Million USD | -389.11% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -13866.717% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -576.778% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -17276.974% |
| Moolec Science SA | 13.94 Million USD | -11816.225% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -3750.945% |
| Geron Corporation | 146.12 Million USD | -1037.203% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -3188.53% |
| Royalty Pharma plc | 6.29 Billion USD | 73.613% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -4077.796% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -564345.018% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -67443.477% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -778.513% |
| Humacyte, Inc. | 114.67 Million USD | -1349.079% |
| Structure Therapeutics Inc. | 29.05 Million USD | -5620.146% |
| 89bio, Inc. | 59.96 Million USD | -2671.309% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -6179.56% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -138843.144% |
| Genelux Corporation | 8.42 Million USD | -19635.867% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -24138.04% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1119.023% |
| Notable Labs, Ltd. | 4.42 Million USD | -37436.932% |
| Liquidia Corporation | 73.13 Million USD | -2172.088% |
| Mustang Bio, Inc. | 17.61 Million USD | -9331.636% |
| Immunovant, Inc. | 48.95 Million USD | -3294.464% |
| Quantum-Si incorporated | 26.63 Million USD | -6139.946% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -4229.417% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -53453.335% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2149.848% |
| Acasti Pharma Inc. | 11.55 Million USD | -14278.818% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -7250.406% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -61029.942% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -4406.223% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -121833.43% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -27159.843% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -6591.202% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -7067.702% |
| PepGen Inc. | 34.63 Million USD | -4698.475% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -13583.794% |
| United Therapeutics Corporation | 1.18 Billion USD | -40.565% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -23693.814% |
| Solid Biosciences Inc. | 38.45 Million USD | -4220.974% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -19319.452% |
| Immuneering Corporation | 12 Million USD | -13738.365% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -529362.368% |
| Silo Pharma, Inc. | 1.56 Million USD | -105793.823% |
| Belite Bio, Inc | 4.21 Million USD | -39362.36% |
| XOMA Corporation | 145.58 Million USD | -1041.475% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -68341.516% |
| Bionomics Limited | 10.15 Million USD | -16257.965% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -7632.353% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -7152.477% |
| uniQure N.V. | 624.01 Million USD | -166.3% |
| Cassava Sciences, Inc. | 14.19 Million USD | -11606.657% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -919518.596% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -876.449% |
| Forte Biosciences, Inc. | 3.66 Million USD | -45228.969% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -637608.523% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -24529.613% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -21534.683% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -9459.685% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -15624.451% |
| Altimmune, Inc. | 16.54 Million USD | -9946.309% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -169.021% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -7152.477% |
| Compugen Ltd. | 55.77 Million USD | -2879.399% |
| Peak Bio, Inc. | 20.75 Million USD | -7907.184% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1404.359% |
| Benitec Biopharma Inc. | 4.96 Million USD | -33389.722% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -952.793% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -2110.552% |
| Zura Bio Limited | 21.29 Million USD | -7704.621% |
| PolyPid Ltd. | 17.46 Million USD | -9413.167% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1378.447% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -2110.552% |
| Instil Bio, Inc. | 99.8 Million USD | -1565.073% |
| argenx SE | 444.95 Million USD | -273.47% |
| Immunome, Inc. | 28.65 Million USD | -5698.59% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -19832.35% |
| Verona Pharma plc | 58.84 Million USD | -2724.153% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -11381.794% |
| Shattuck Labs, Inc. | 14.85 Million USD | -11083.525% |
| CervoMed Inc. | 2.59 Million USD | -63918.566% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -33994.378% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -12947.739% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -15673.707% |
| Moolec Science SA | 13.94 Million USD | -11816.225% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -70809.203% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2889.03% |
| AnaptysBio, Inc. | 364.28 Million USD | -356.169% |
| Design Therapeutics, Inc. | 11.95 Million USD | -13798.963% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -13001.23% |
| NeurAxis, Inc. | 1.91 Million USD | -86778.555% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -4168.804% |
| Lumos Pharma, Inc. | 13.33 Million USD | -12363.512% |
| Achilles Therapeutics plc | 19.08 Million USD | -8606.24% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -11381.794% |
| 180 Life Sciences Corp. | 5.38 Million USD | -30746.399% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -6944.941% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -7201.316% |
| Nutriband Inc. | 1.07 Million USD | -153920.83% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -5330.943% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -11351.726% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -314.121% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -5017.359% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -12634.675% |
| Palisade Bio, Inc. | 2.73 Million USD | -60570.318% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -31534.495% |
| Beam Therapeutics Inc. | 478.38 Million USD | -247.369% |
| Neurogene Inc. | 36.54 Million USD | -4446.663% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -317.579% |
| AEON Biopharma, Inc. | 159.88 Million USD | -939.321% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -3387.429% |
| Sesen Bio, Inc. | 30.98 Million USD | -5263.284% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -6300.986% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -21758.89% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -748.972% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -765.243% |
| Athira Pharma, Inc. | 30.05 Million USD | -5428.695% |
| Vaccinex, Inc. | 5.94 Million USD | -27866.341% |
| HCW Biologics Inc. | 15.05 Million USD | -10940.169% |
| XOMA Corporation | 145.58 Million USD | -1041.475% |
| Nektar Therapeutics | 267.04 Million USD | -522.275% |
| Arvinas, Inc. | 644.6 Million USD | -157.797% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -9270.935% |
| Merus N.V. | 102.15 Million USD | -1526.768% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1035.47% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1647.014% |
| Rezolute, Inc. | 11.73 Million USD | -14061.923% |
| Clene Inc. | 38.95 Million USD | -4166.283% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -58261.02% |
| BeyondSpring Inc. | 48.26 Million USD | -3342.706% |
| Synlogic, Inc. | 32.89 Million USD | -4951.71% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -11271.792% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -101598.898% |
| Peak Bio, Inc. | 20.75 Million USD | -7907.184% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -2518.636% |
| Krystal Biotech, Inc. | 39.71 Million USD | -4084.318% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -341.202% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1568.953% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -383921.298% |
| MannKind Corporation | 721.36 Million USD | -130.363% |
| Ikena Oncology, Inc. | 22.33 Million USD | -7340.161% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -79562.512% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1519.807% |
| Gossamer Bio, Inc. | 249.14 Million USD | -566.98% |
| CohBar, Inc. | 1.03 Million USD | -160668.083% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -15446.45% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8624.066% |
| Legend Biotech Corporation | 589.93 Million USD | -181.686% |
| Mural Oncology plc | 37.92 Million USD | -4281.354% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1152.873% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -72297.37% |
| Disc Medicine, Inc. | 22.87 Million USD | -7164.525% |
| Champions Oncology, Inc. | 28.03 Million USD | -5827.448% |
| REGENXBIO Inc. | 262.22 Million USD | -533.708% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -49366.683% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -13158.018% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -12271.993% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -7736.642% |
| Vaxart, Inc. | 34.02 Million USD | -4783.938% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -8050.172% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -5724.222% |
| Cellectis S.A. | 249.57 Million USD | -565.836% |
| Longeveron Inc. | 5.33 Million USD | -31036.594% |
| Repare Therapeutics Inc. | 41.81 Million USD | -3873.696% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 30.911% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -2652.717% |
| Revolution Medicines, Inc. | 262.39 Million USD | -533.3% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -78768.533% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -19164.549% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -13981.519% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -11733.369% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -77155.23% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 67.732% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1251.431% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -29761.485% |
| Veru Inc. | 32.81 Million USD | -4964.38% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -24092.168% |
| Cingulate Inc. | 10.36 Million USD | -15938.815% |
| Passage Bio, Inc. | 39.26 Million USD | -4132.489% |
| Context Therapeutics Inc. | 4.19 Million USD | -39543.917% |
| Exicure, Inc. | 8.54 Million USD | -19338.063% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -5531.558% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -15747.416% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -7439.404% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -919.572% |
| Nuvalent, Inc. | 31.82 Million USD | -5121.884% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -26021.62% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -2536.794% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -9132.0% |
| OmniAb, Inc. | 87.4 Million USD | -1801.327% |
| Anew Medical, Inc. | 8.24 Million USD | -20062.588% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -4240.035% |
| Lipocine Inc. | 2.63 Million USD | -63045.679% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -6225.213% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -4032.498% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -6137.414% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1828.825% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -30667.636% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1908.242% |
| Ocugen, Inc. | 23.98 Million USD | -6828.908% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -3480.839% |
| Q32 Bio Inc. | 233.12 Million USD | -612.81% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -18229.583% |
| Alumis Inc. Common Stock | 53.5 Million USD | -3005.977% |
| Equillium, Inc. | 27.95 Million USD | -5843.985% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -704.368% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -29433.658% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -26995.527% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -956.253% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -2293.329% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -16560.583% |
| Dominari Holdings Inc. | 4.63 Million USD | -35752.427% |
| Edesa Biotech, Inc. | 1.84 Million USD | -90132.766% |
| vTv Therapeutics Inc. | 29.56 Million USD | -5520.32% |
| Bio-Techne Corporation | 744.34 Million USD | -123.253% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1217.822% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -382.43% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -3995.527% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -5638.716% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1699.22% |
| Nkarta, Inc. | 105.6 Million USD | -1473.636% |
| BioCardia, Inc. | 4.59 Million USD | -36103.922% |
| Iterum Therapeutics plc | 32.66 Million USD | -4987.747% |